Therefore, the correlations between BGN levels and immunotherapy response were analyzed in multiple cancers, including urothelial cancer, basal cell carcinoma, non‐small cell lung cancer, clear cell renal cell carcinoma (ccRCC) and breast cancer. This evidence concerns the gene BGN and lung cancer.